Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer, Social Media & Clinical Trials: Lipset Explains
Pharmalot
Monday, March 12, 2012 - 5:33pm
tags:
Pfizer, social media, clinical trials, overactive bladder, Detrol
Teva Pharmaceutical Seeks to Intervene in Plan B Lawsuit
Bloomberg
Monday, March 12, 2012 - 5:32pm
tags:
Teva Pharmaceuticals, Plan B contraceptive, One Step
Enzon Reports Fourth-Quarter and Full-Year 2011 Results
Yahoo
Monday, March 12, 2012 - 5:31pm
tags:
earnings, Enzon
Johnson & Johnson: A Solid Buy Candidate For 2012
Seeking Alpha
Monday, March 12, 2012 - 5:30pm
tags:
JNJ
Bio-Pharma Watch List: 2 Week Report Card
Seeking Alpha
Monday, March 12, 2012 - 5:30pm
tags:
Spectrum Pharmaceuticals, Acadia, Antares Pharma, BioSante, Indenix
BrainStorm Cell initiates study for MS
The Fly on the Wall
Monday, March 12, 2012 - 5:28pm
tags:
MS, multiple sclerosis, BrainStorm Cell Therapeutics, stem cells
Oncothyreon At $5: Buy Time Or Sign Of Trouble?
Seeking Alpha
Monday, March 12, 2012 - 10:43am
tags:
Oncothyreon
Ardea Posts Lower Revs, Wider Loss
Yahoo/Zacks
Monday, March 12, 2012 - 10:41am
tags:
earnings, Ardea
Pfizer Says Study Backs Use of Top Vaccine in Older Children
Bloomberg
Monday, March 12, 2012 - 10:28am
tags:
vaccines, Pfizer, Prevnar 13
Tranzyme bowel drug fails trial, shares crash
Reuters
Monday, March 12, 2012 - 10:25am
tags:
Tranzyme, ulimorelin
Sihuan prepares anti-hypertension drug for clinical trial in China
Reuters
Monday, March 12, 2012 - 10:24am
tags:
China, antihypertensives, Sihuan, Tylerdipine Hydrochloride
Good News For Alnylam: PBL Making Baulcombe Patent Widely Available
Seeking Alpha
Sunday, March 11, 2012 - 12:13pm
tags:
Alnylam, RNAi
Dendreon Faces New Competition As J&J Impresses With Prostate Cancer Drug
Seeking Alpha
Sunday, March 11, 2012 - 12:12pm
tags:
Zytiga, Provenge, prostate cancer, JNJ, Dendreon
Bayer AG : Bayer Sticks To Target Of Doubling Sales In China By 2015-Report
4-Traders
Sunday, March 11, 2012 - 12:10pm
tags:
Bayer AG
MAP Pharma: Making Money From Migraines
Seeking Alpha
Sunday, March 11, 2012 - 12:09pm
tags:
MAP Pharmaceuticals, Levadex, migraines
Pfizer's $150M Bet On Acura Pharmaceuticals Is Good News For Investors
Seeking Alpha
Sunday, March 11, 2012 - 12:06pm
tags:
Pfizer, Acura
CEO Gaffe of the Week: AstraZeneca
Motley Fool
Sunday, March 11, 2012 - 12:00pm
tags:
AstraZeneca
8 Reasons To Buy This $1.30 Lottery Ticket
Seeking Alpha
Sunday, March 11, 2012 - 11:57am
tags:
Novavax
5 Biotech Stocks Undervalued By EPS Trends
Seeking Alpha
Sunday, March 11, 2012 - 11:56am
tags:
Anika, Amgen, Illumina, Questcor Pharmaceuticals, ViroPharma
Bionovo says company may cease operations without additional funding
Yahoo/theflyonthewall.com
Sunday, March 11, 2012 - 11:55am
tags:
Bionovo

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.